Show Summary Details
Page of

Drug-control policies: a question of balance 

Drug-control policies: a question of balance
Chapter:
Drug-control policies: a question of balance
Author(s):

Martin Plant

, Roy Robertson

, Moira Plant

, and Patrick Miller

DOI:
10.1093/med/9780199544790.003.005
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 20 April 2019

There are many different views on the best way to reduce drug-related problems. Drugs are controversial. Opinions on the best way to deal with them cover the entire spectrum from legalization to tight controls backed up by severe penalties. In fact most of the ‘official’ and public debate about drug policy reflects the view that drugs are intrinsically ‘bad’ and should somehow be controlled. The authors of this book do not wish to embrace any particular approach to drug control. They do not believe that any single known approach is a magic solution, offering a panacea to something as complex and multi-faceted as drug use and its associated adverse effects. Even so, it is hoped that this chapter will provide an insight into some of the debates and arguments that relate to the nature and status of drug use and the options that are available with which to respond to it. It might also be possible to envisage ways of mitigating the damaging consequences outlined in the previous chapter without having to embark on a political crusade or to turn around the juggernaut of international condemnation of drug use and drug users.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.